
Topiramate
CAS No. 97240-79-4
Topiramate( McN 4853 | RWJ 17021 | TPM )
Catalog No. M16879 CAS No. 97240-79-4
Topiramate (brand name Topamax) is an anticonvulsant drug produced by Ortho-McNeil Neurologics.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
25MG | 34 | In Stock |
![]() ![]() |
50MG | 45 | In Stock |
![]() ![]() |
100MG | 59 | In Stock |
![]() ![]() |
200MG | 101 | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameTopiramate
-
NoteResearch use only, not for human use.
-
Brief DescriptionTopiramate (brand name Topamax) is an anticonvulsant drug produced by Ortho-McNeil Neurologics.
-
DescriptionTopiramate (brand name Topamax) is an anticonvulsant drug produced by Ortho-McNeil Neurologics, a division of Johnson & Johnson. It is used to treat epilepsy in both children and adults. In children it is also indicated for treatment of Lennox-Gastaut syndrome (a disorder that causes seizures and developmental delays). It is also Food and Drug Administration (FDA) approved for, and now most frequently prescribed for, the prevention of migraines. A combination product containing phentermine and topiramate extended-release called QSYMIA is indicated for the management of obesity. (In Vitro):Topiramate has been believed to be a type of antiepileptic drug that blocks spread of seizures. Thus far, the mechanisms of its actions have been proven to include use-dependent inhibition of voltage-dependent Na+ channels in neurons, potentiation of GABA (γ-amino-butyric acid)-induced Cl- influx, and inhibitory effects on inward currents by antagonizing kainate/alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors.
-
In VitroTopiramate has been believed to be a type of antiepileptic drug that blocks spread of seizures. Thus far, the mechanisms of its actions have been proven to include use-dependent inhibition of voltage-dependent Na+ channels in neurons, potentiation of GABA (γ-amino-butyric acid)-induced Cl- influx, and inhibitory effects on inward currents by antagonizing kainate/alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors.
-
In Vivo——
-
SynonymsMcN 4853 | RWJ 17021 | TPM
-
PathwayMembrane Transporter/Ion Channel
-
TargetCarbonic Anhydrase
-
RecptorCarbonic anhydrase| GABAR| mGluR5
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number97240-79-4
-
Formula Weight339.36
-
Molecular FormulaC12H21NO8S
-
Purity>98% (HPLC)
-
SolubilityEthanol: 68 mg/mL (200.37 mM); DMSO: 68 mg/mL (200.37 mM)
-
SMILESCC1(O[C@H]([C@@H](CO[C@@]2(COS(=O)(N)=O)O3)O1)[C@@H]2OC3(C)C)C
-
Chemical Name((3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-3a-yl)methyl sulfamate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Nowakowska E, et al. Arzneimittelforschung. 2009;59(10):487-92.
molnova catalog



related products
-
SLC-0111
SLC-0111 is a sulfonamide carbonic anhydrase (CA, EC 4.2.1.1) inhibitor with IC50 of 45 nM and 4.5 nM for tumor-associated enzymes hCA IX and hCA XII.
-
Benzthiazide
Benzthiazide is used to treat hypertension and edema. Like other thiazides, benzthiazide promotes water loss from the body (diuretics).
-
Chlorothiazide
Chlorothiazide is a diuretic and antihypertensive.